News from insightec ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

14 May, 2015, 11:31 BST INSIGHTEC Announces Launch of Neurosurgery System on 1.5T MRI Platform

Expanded capability brings noninvasive MR-guided focused ultrasound to broader market INSIGHTEC Ltd, the leader in MR-guided Focused Ultrasound...


04 Jul, 2014, 03:00 BST Taipei Medical University-Taipei Cancer Center Offers a New and Noninvasive Treatment for Bone Cancer Pain

Taipei Medical University-Taipei Cancer Center (TMU-TCC) announced today that its Taipei Cancer Center (TCC) is now offering a new technology,...


22 Aug, 2013, 13:00 BST ExAblate Receives Approval of Health Canada for the Treatment of Uterine Fibroids and Pain Palliation of Bone Metastases

InSightec Ltd, the leader in MR guided Focused Ultrasound therapy, announced that its ExAblate system received approval of Health Canada for MRgFUS...


29 Jul, 2013, 07:30 BST ExAblate Receives Approval of Chinese Food and Drug Administration

Non-invasive MR guided Focused Ultrasound treatment now available for millions of Chinese women suffering from uterine fibroids InSightec Ltd, the...


01 Jul, 2013, 10:00 BST ExAblate Receives Extended CE Mark Certification for Benign and Cancerous Bone Tumors

-- Indications include treatment of bone metastases, multiple myeloma, osteoid osteoma, facet joints, and other bone tumors -- InSightec Ltd, the...


04 Dec, 2012, 11:38 GMT InSightec's ExAblate Neuro System Awarded European CE Mark for Non-invasive Treatment of Neurological Disorders in the Brain

ExAblate treatment is indicated for use for essential tremor, tremor dominant Parkinson's disease and neuropathic pain InSightec Ltd. announced that...


22 Oct, 2012, 12:46 BST FDA Approves New Non-Invasive, Non-Ionizing Radiation Therapy to Treat Pain from Bone Metastases

ExAblate® MRI-guided Focused Ultrasound is effective in reducing pain from bone metastases in patients who could not undergo radiation therapy;...


24 Jan, 2012, 09:00 GMT InSightec Submits Pre Market Application (PMA) for FDA Approval of ExAblate for Treatment of Painful Bone Metastases

FDA Will Evaluate Submission Through an Expedited Review Process InSightec Ltd, the leader in MR guided Focused Ultrasound therapy, announced that it ...


03 Jan, 2012, 09:30 GMT Enrollment in First MRgFUS Essential Tremor Feasibility Trial Completed

---- January issue of Neurosurgical Focus devoted to MRgFUS brain research ---- InSightec Ltd, the global leader in MR guided Focused Ultrasound...


27 Nov, 2011, 09:00 GMT NICE Issues Updated Guidance for MR Guided Focused Ultrasound for Uterine Fibroids

- Evidence Sufficient to Support the Use of This Procedure With Normal Arrangements - InSightec Ltd announced that NICE, the National Institute for...


21 Sep, 2011, 08:00 BST ExAblate® Neuro has Been Used to Treat 30 Patients with Chronic Neurological Disorders such as Essential Tremor, Neuropathic Pain and Parkinson's Disease

InSightec Ltd., the global leader in MR guided Focused Ultrasound (MRgFUS) technology, announced today that its investigational ExAblate® Neuro...


21 Sep, 2011, 08:00 BST ExAblate® Neuro zur Behandlung von 30 Patienten mit chronischen neurologischen Erkrankungen wie essentiellem Tremor, neuropathischen Schmerzen und Parkinsonkrankheit eingesetzt

InSightec Ltd., globaler Marktführer im Bereich MR-geführte fokussierte Ultraschalltechnologie (MRgFUS), gab heute bekannt, dass das vom Unternehmen...


21 Sep, 2011, 08:00 BST ExAblate® Neuro a été utilisé pour traiter 30 patients présentant des troubles neurologiques chroniques comme le tremblement essentiel, la douleur neuropathique et la maladie de Parkinson

InSightec Ltd., le leader mondial en matière de technologie par ultrasons focalisés guidés par RM (MRgFUS), a annoncé aujourd'hui que le système...


13 Jul, 2011, 14:00 BST 23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated in Clinical Trials Using the ExAblate(R) Non-Invasive Prostate Cancer System

Initial Results are Encouraging, Spurring Hope for a Treatment Option With a Lower Rate of Complications InSightec Ltd., the global leader in...


13 Jul, 2011, 09:00 BST 23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated in Clinical Trials Using the ExAblate(R) Non-Invasive Prostate Cancer System

Initial Results are Encouraging, Spurring Hope for a Treatment Option With a Lower Rate of Complications InSightec Ltd., the global leader in...